GSK Plc (GLAXF)
26.12
+1.22
(+4.92%)
USD |
OTCM |
Oct 26, 16:00
GSK Price : 26.12 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 26.12 | 26.12 | 26.12 | 26.12 | 110.00 |
| Oct 23, 2026 | 24.90 | 24.90 | 24.90 | 24.90 | 0.000 |
| Oct 22, 2026 | 24.90 | 24.90 | 24.90 | 24.90 | 521.00 |
| Oct 21, 2026 | 24.90 | 24.90 | 24.90 | 24.90 | 511.00 |
| Oct 20, 2026 | 24.74 | 24.74 | 24.74 | 24.74 | 3.000 |
| Oct 19, 2026 | 23.70 | 24.74 | 23.70 | 24.74 | 647.00 |
| Oct 16, 2026 | 24.44 | 24.44 | 24.44 | 24.44 | 2988.00 |
| Oct 15, 2026 | 24.42 | 24.42 | 24.42 | 24.42 | 153.00 |
| Oct 14, 2026 | 23.65 | 23.65 | 23.65 | 23.65 | 395.00 |
| Oct 13, 2026 | 24.53 | 24.53 | 24.53 | 24.53 | 0.000 |
| Oct 12, 2026 | 24.53 | 24.53 | 24.53 | 24.53 | 58.00 |
| Oct 09, 2026 | 24.53 | 24.53 | 24.53 | 24.53 | 2542.00 |
| Oct 08, 2026 | 24.53 | 24.53 | 24.53 | 24.53 | 48.00 |
| Oct 07, 2026 | 24.53 | 24.53 | 24.53 | 24.53 | 0.000 |
| Oct 06, 2026 | 23.52 | 24.53 | 22.72 | 24.53 | 13420.00 |
| Oct 05, 2026 | 22.50 | 23.55 | 22.50 | 23.55 | 2531.00 |
| Oct 02, 2026 | 22.77 | 22.77 | 22.77 | 22.77 | 44.00 |
| Oct 01, 2026 | 24.00 | 24.00 | 22.77 | 22.77 | 1100.00 |
| Sep 30, 2026 | 24.00 | 24.00 | 24.00 | 24.00 | 6.000 |
| Sep 29, 2026 | 24.00 | 24.00 | 24.00 | 24.00 | 1.000 |
| Sep 28, 2026 | 24.00 | 24.00 | 24.00 | 24.00 | 378.00 |
| Sep 25, 2026 | 24.38 | 24.38 | 24.38 | 24.38 | 250.00 |
| Sep 24, 2026 | 24.26 | 24.26 | 24.26 | 24.26 | 5.000 |
| Sep 23, 2026 | 23.61 | 24.36 | 23.61 | 24.26 | 697.00 |
| Sep 22, 2026 | 24.95 | 24.95 | 24.95 | 24.95 | 69.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 172.06 |
| Hikma Pharmaceuticals Plc | 22.14 |
| Allergy Therapeutics Plc | 0.15 |
| Shield Therapeutics Plc | 0.0736 |
| Futura Medical Plc | 0.002 |
Price Related Metrics
| PE Ratio | 16.46 |
| PS Ratio | 2.392 |
| PEG Ratio | 0.3433 |
| Price to Book Value | 4.512 |
| Price to Free Cash Flow | 16.23 |
| Earnings Yield | 6.08% |
| Market Cap | 105.67B |
| PEGY Ratio | 0.32 |
| Operating PE Ratio | 9.570 |
| Normalized PE Ratio | 11.33 |